Shilpa Medicare's Stock Declines by -5.33% in Line with Sector Performance

Shilpa Medicare, a midcap pharmaceutical company, saw a decline of -5.33% in its stock price on May 17, 2024. This drop was in line with the overall performance of the sector, as the company underperformed by -4.06%. The stock had been on an upward trend for the past three days, but this trend was reversed with the recent decline. On the day of the decline, Shilpa Medicare's stock touched an intraday low of Rs 500, which was a decrease of -4.24%. However, the stock is still performing well in the long term, with its moving averages higher than the 50-day, 100-day, and 200-day moving averages. It is worth noting that the stock is currently lower than the 5-day and 20-day moving averages. In comparison to the overall market performance, Shilpa Medicare's stock saw a decline of -4.43% in just one day, while the Sensex saw a positive performance of 0.36%. In the past month, the stock has seen a decline of -7.67%, while the Sensex has seen a positive performance of 1.35%. Despite the recent decline, MarketsMOJO has given a 'Hold' rating for Shilpa Medicare's stock. This indicates that the company's stock is expected to perform steadily in the near future. As a midcap pharmaceutical company, Shilpa Medicare continues to be a strong player in the industry, with its stock showing promising long-term performance.